Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. BNP Paribas
  6. News
  7. Summary
    BNP   FR0000131104

BNP PARIBAS

(BNP)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Invasive insects and climate change : Impact on the world economy

10/05/2016 | 10:14am EDT

Even more worrying, insects in general weigh greatly on agriculture by consuming around 40% of agricultural production. 'The equivalent of enough food to feed one million humans', highlights Franck Courchamp. Among the main farming nations affected by this threat, China and the United States represent the biggest risks in terms of this threat.

In terms of health, the overall cost attributed to invasive insects exceeds $6.9bn per year. These costs do not take into account malaria, for which the majority of spending is not related to an infestation but to an insect which is naturally present. Moreover, this assessment excludes the economic impact on productivity, revenue, tourism, blood supplies, individual protection measures and quality of life. Most of the estimates for health costs are a combination of direct and indirect costs which are often related to medical care.

According to the research team, greater vigilance and the implementation of response procedures for a biological invasion would help society save tens of billions of euros. These preventive measures could divide the cost of mosquito-borne diseases by at least ten.

Researchers suggest, among other measures: strategic spending in the funding of research into the assessment and prevention of invasive species, the implementation of countermeasures adapted to each threat and the support of public awareness campaigns on the risks of introducing certain species. Finally, there is a major need to develop the network of associations in order for measures to fight against these invasive species are extended on the ground.

BNP Paribas SA published this content on 05 October 2016 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 05 October 2016 14:14:06 UTC.


© Publicnow 2016
All news about BNP PARIBAS
12:58pBNP PARIBAS : Looking beyond the peak in growth
PU
07/22BAWAG GROUP AG (WBAG : BG) signed an agreement to acquire BNP Paribas S.A. Niede..
CI
07/20BNP PARIBAS : Goldman Sachs maintains a Buy rating
MD
07/16RETAIL : How does 'unified commerce' rethink the customer journey and payment ex..
PU
07/16Metron, SAS announced that it has received €19 million in funding from BNP Pa..
CI
07/15BNP PARIBAS : Public Offer - issued amount
PU
07/15BNP Paribas SA Provides Update on Worst-Of Phoenix Snowball Notes Linked to B..
CI
07/14BNP PARIBAS : RBC keeps its Buy rating
MD
07/132021 SUMMER FESTIVALS : the BNP Paribas Foundation alongside artists
PU
07/13BNP PARIBAS : Takes Full Control of Exane
MT
More news
Financials
Sales 2021 45 312 M 53 323 M 53 323 M
Net income 2021 7 553 M 8 888 M 8 888 M
Net Debt 2021 - - -
P/E ratio 2021 8,48x
Yield 2021 6,51%
Capitalization 63 166 M 74 304 M 74 334 M
Capi. / Sales 2021 1,39x
Capi. / Sales 2022 1,37x
Nbr of Employees 193 000
Free-Float 86,7%
Chart BNP PARIBAS
Duration : Period :
BNP Paribas Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BNP PARIBAS
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 24
Last Close Price 50,57 €
Average target price 61,46 €
Spread / Average Target 21,5%
EPS Revisions
Managers and Directors
Jean-Laurent Bonnafé Chief Executive Officer & Director
Jean Lemierre Chairman
Bernard Gavgani Chief Information Officer
Yann Gérardin Chief Operating Officer
Nathalie Hartmann Head-Compliance
Sector and Competitors